Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of antidiabetic drugs. Its structure supports the design of enzyme inhibitors that target metabolic pathways. The presence of both hydroxyl and difluoromethyl groups allows for selective interactions with biological targets, enhancing drug potency and metabolic stability. Commonly employed in medicinal chemistry for optimizing pharmacokinetic properties in small molecule therapeutics.